VINEET LABORATORIES | TYCHE INDUSTRIES | VINEET LABORATORIES/ TYCHE INDUSTRIES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -11.2 | 14.8 | - | View Chart |
P/BV | x | 1.3 | 1.5 | 86.7% | View Chart |
Dividend Yield | % | 0.0 | 1.3 | - |
VINEET LABORATORIES TYCHE INDUSTRIES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
VINEET LABORATORIES Mar-24 |
TYCHE INDUSTRIES Mar-24 |
VINEET LABORATORIES/ TYCHE INDUSTRIES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 89 | 219 | 40.6% | |
Low | Rs | 42 | 137 | 30.3% | |
Sales per share (Unadj.) | Rs | 163.3 | 67.8 | 240.8% | |
Earnings per share (Unadj.) | Rs | 1.1 | 11.9 | 9.3% | |
Cash flow per share (Unadj.) | Rs | 3.8 | 13.8 | 27.8% | |
Dividends per share (Unadj.) | Rs | 0 | 2.50 | 0.0% | |
Avg Dividend yield | % | 0 | 1.4 | 0.0% | |
Book value per share (Unadj.) | Rs | 37.7 | 123.6 | 30.5% | |
Shares outstanding (eoy) | m | 9.22 | 10.25 | 90.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.4 | 2.6 | 15.2% | |
Avg P/E ratio | x | 58.6 | 14.9 | 392.9% | |
P/CF ratio (eoy) | x | 17.0 | 12.9 | 131.8% | |
Price / Book Value ratio | x | 1.7 | 1.4 | 120.3% | |
Dividend payout | % | 0 | 20.9 | 0.0% | |
Avg Mkt Cap | Rs m | 602 | 1,825 | 33.0% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 64 | 78 | 81.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 1,506 | 695 | 216.6% | |
Other income | Rs m | 5 | 59 | 7.8% | |
Total revenues | Rs m | 1,511 | 754 | 200.2% | |
Gross profit | Rs m | 72 | 126 | 56.9% | |
Depreciation | Rs m | 25 | 19 | 129.8% | |
Interest | Rs m | 48 | 0 | 239,050.0% | |
Profit before tax | Rs m | 4 | 166 | 2.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | -7 | 44 | -15.1% | |
Profit after tax | Rs m | 10 | 122 | 8.4% | |
Gross profit margin | % | 4.8 | 18.2 | 26.3% | |
Effective tax rate | % | -182.8 | 26.4 | -693.3% | |
Net profit margin | % | 0.7 | 17.6 | 3.9% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 882 | 1,167 | 75.6% | |
Current liabilities | Rs m | 760 | 103 | 739.3% | |
Net working cap to sales | % | 8.1 | 153.0 | 5.3% | |
Current ratio | x | 1.2 | 11.3 | 10.2% | |
Inventory Days | Days | 4 | 31 | 13.7% | |
Debtors Days | Days | 766 | 1,004 | 76.3% | |
Net fixed assets | Rs m | 287 | 239 | 120.3% | |
Share capital | Rs m | 92 | 102 | 90.0% | |
"Free" reserves | Rs m | 255 | 1,165 | 21.9% | |
Net worth | Rs m | 347 | 1,267 | 27.4% | |
Long term debt | Rs m | 39 | 0 | - | |
Total assets | Rs m | 1,169 | 1,405 | 83.2% | |
Interest coverage | x | 1.1 | 8,315.5 | 0.0% | |
Debt to equity ratio | x | 0.1 | 0 | - | |
Sales to assets ratio | x | 1.3 | 0.5 | 260.4% | |
Return on assets | % | 5.0 | 8.7 | 57.0% | |
Return on equity | % | 3.0 | 9.7 | 30.6% | |
Return on capital | % | 13.3 | 13.1 | 101.5% | |
Exports to sales | % | 0 | 64.6 | 0.0% | |
Imports to sales | % | 0 | 10.9 | 0.0% | |
Exports (fob) | Rs m | NA | 449 | 0.0% | |
Imports (cif) | Rs m | NA | 76 | 0.0% | |
Fx inflow | Rs m | 0 | 449 | 0.0% | |
Fx outflow | Rs m | 153 | 89 | 171.1% | |
Net fx | Rs m | -153 | 359 | -42.6% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -114 | 77 | -148.1% | |
From Investments | Rs m | 3 | 39 | 8.4% | |
From Financial Activity | Rs m | 107 | -20 | -522.1% | |
Net Cashflow | Rs m | -4 | 96 | -4.2% |
Indian Promoters | % | 36.1 | 62.0 | 58.2% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 63.9 | 38.0 | 168.1% | |
Shareholders | 10,300 | 7,264 | 141.8% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare VINEET LABORATORIES With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB MANKIND PHARMA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | VINEET LABORATORIES | TYCHE INDUSTRIES | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.87% | -3.64% | 0.11% |
1-Month | -13.92% | 3.53% | -3.22% |
1-Year | -25.30% | 5.93% | 42.65% |
3-Year CAGR | -12.72% | 2.77% | 19.86% |
5-Year CAGR | 1.21% | 18.44% | 25.90% |
* Compound Annual Growth Rate
Here are more details on the VINEET LABORATORIES share price and the TYCHE INDUSTRIES share price.
Moving on to shareholding structures...
The promoters of VINEET LABORATORIES hold a 36.1% stake in the company. In case of TYCHE INDUSTRIES the stake stands at 62.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of VINEET LABORATORIES and the shareholding pattern of TYCHE INDUSTRIES.
Finally, a word on dividends...
In the most recent financial year, VINEET LABORATORIES paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
TYCHE INDUSTRIES paid Rs 2.5, and its dividend payout ratio stood at 20.9%.
You may visit here to review the dividend history of VINEET LABORATORIES, and the dividend history of TYCHE INDUSTRIES.
For a sector overview, read our pharmaceuticals sector report.
On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.